| 1 | [SID103224720] | Active | IC50 | 0.04 | DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) [AID625223, Type: other] | Sigma non-opioid intracellular receptor 1 [gi:74752153] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.04 [uM] | | BioAssay | DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) | | AID | 625223 | | BioAssay type | other | | Target | Sigma non-opioid intracellular receptor 1 [gi:74752153] | | PubMed | | | Data Table |  |
|
| 2 | [SID103224720] | Active | IC50 | 0.04 | DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) [AID625223, Type: other] | Sigma non-opioid intracellular receptor 1 [gi:74752153] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.04 [uM] | | BioAssay | DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol) | | AID | 625223 | | BioAssay type | other | | Target | Sigma non-opioid intracellular receptor 1 [gi:74752153] | | PubMed | | | Data Table |  |
|
| 3 | [SID103224720] | Active | IC50 | 0.074 | DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) [AID625269, Type: other] | Histamine H1 receptor [gi:547645] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.074 [uM] | | BioAssay | DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) | | AID | 625269 | | BioAssay type | other | | Target | Histamine H1 receptor [gi:547645] | | PubMed | | | Data Table |  |
|
| 4 | [SID103224720] | Active | IC50 | 0.074 | DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) [AID625269, Type: other] | Histamine H1 receptor [gi:547645] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.074 [uM] | | BioAssay | DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine) | | AID | 625269 | | BioAssay type | other | | Target | Histamine H1 receptor [gi:547645] | | PubMed | | | Data Table |  |
|
| 5 | [SID103224720] | Active | IC50 | 0.161 | DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil) [AID625224, Type: other] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.161 [uM] | | BioAssay | DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil) | | AID | 625224 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID103224720] | Active | IC50 | 0.252 | DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) [AID625254, Type: other] | D(3) dopamine receptor [gi:1169206] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.252 [uM] | | BioAssay | DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) | | AID | 625254 | | BioAssay type | other | | Target | D(3) dopamine receptor [gi:1169206] | | PubMed | | | Data Table |  |
|
| 7 | [SID103224720] | Active | IC50 | 0.252 | DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) [AID625254, Type: other] | D(3) dopamine receptor [gi:1169206] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.252 [uM] | | BioAssay | DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) | | AID | 625254 | | BioAssay type | other | | Target | D(3) dopamine receptor [gi:1169206] | | PubMed | | | Data Table |  |
|
| 8 | [SID103224720] | Active | IC50 | 0.252 | DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) [AID625254, Type: other] | D(3) dopamine receptor [gi:1169206] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.252 [uM] | | BioAssay | DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) | | AID | 625254 | | BioAssay type | other | | Target | D(3) dopamine receptor [gi:1169206] | | PubMed | | | Data Table |  |
|
| 9 | [SID103224720] | Active | IC50 | 0.252 | DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) [AID625254, Type: other] | D(3) dopamine receptor [gi:1169206] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.252 [uM] | | BioAssay | DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone) | | AID | 625254 | | BioAssay type | other | | Target | D(3) dopamine receptor [gi:1169206] | | PubMed | | | Data Table |  |
|
| 10 | [SID103224720] | Active | IC50 | 0.36 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) [AID625192, Type: other] | 5-hydroxytryptamine receptor 2A [gi:543727] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.36 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) | | AID | 625192 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2A [gi:543727] | | PubMed | | | Data Table |  |
|
| 11 | [SID103224720] | Active | IC50 | 0.36 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) [AID625192, Type: other] | 5-hydroxytryptamine receptor 2A [gi:543727] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.36 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) | | AID | 625192 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2A [gi:543727] | | PubMed | | | Data Table |  |
|
| 12 | [SID103224720] | Active | IC50 | 0.36 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) [AID625192, Type: other] | 5-hydroxytryptamine receptor 2A [gi:543727] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.36 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin) | | AID | 625192 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2A [gi:543727] | | PubMed | | | Data Table |  |
|
| 13 | [SID103224720] | Active | IC50 | 0.414 | DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin) [AID625225, Type: other] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.414 [uM] | | BioAssay | DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin) | | AID | 625225 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID103224720] | Active | IC50 | 0.44 | Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex [AID205267, Type: Literature] | |   View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.44 [uM] | | BioAssay | Inhibition of binding of Batrachotoxinin [3H]BTX-B to high affinity sites on voltage dependent sodium channels in a vesicular preparation from guinea pig cerebral cortex | | AID | 205267 | | BioAssay type | Literature | | Target | | | PubMed | 2579237 | | Data Table |  |
|
| 15 | [SID103224720] | Active | IC50 | 0.444 | DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) [AID625201, Type: other] | Alpha-2A adrenergic receptor [gi:1351829] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.444 [uM] | | BioAssay | DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) | | AID | 625201 | | BioAssay type | other | | Target | Alpha-2A adrenergic receptor [gi:1351829] | | PubMed | | | Data Table |  |
|
| 16 | [SID103224720] | Active | IC50 | 0.444 | DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) [AID625201, Type: other] | Alpha-2A adrenergic receptor [gi:1351829] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.444 [uM] | | BioAssay | DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912) | | AID | 625201 | | BioAssay type | other | | Target | Alpha-2A adrenergic receptor [gi:1351829] | | PubMed | | | Data Table |  |
|
| 17 | [SID103224720] | Active | IC50 | 0.624 | DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888)) [AID625234, Type: other] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.624 [uM] | | BioAssay | DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888)) | | AID | 625234 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID103224720] | Active | IC50 | 0.652 | DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) [AID625203, Type: other] | Alpha-2C adrenergic receptor [gi:20141211] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.652 [uM] | | BioAssay | DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) | | AID | 625203 | | BioAssay type | other | | Target | Alpha-2C adrenergic receptor [gi:20141211] | | PubMed | | | Data Table |  |
|
| 19 | [SID103224720] | Active | IC50 | 0.652 | DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) [AID625203, Type: other] | Alpha-2C adrenergic receptor [gi:20141211] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.652 [uM] | | BioAssay | DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912) | | AID | 625203 | | BioAssay type | other | | Target | Alpha-2C adrenergic receptor [gi:20141211] | | PubMed | | | Data Table |  |
|
| 20 | [SID103224720] | Active | IC50 | 0.731 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) [AID625217, Type: other] | 5-hydroxytryptamine receptor 2B [gi:1168220] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.731 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) | | AID | 625217 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2B [gi:1168220] | | PubMed | | | Data Table |  |
|
| 21 | [SID103224720] | Active | IC50 | 0.731 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) [AID625217, Type: other] | 5-hydroxytryptamine receptor 2B [gi:1168220] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.731 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) | | AID | 625217 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2B [gi:1168220] | | PubMed | | | Data Table |  |
|
| 22 | [SID103224720] | Active | IC50 | 0.731 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) [AID625217, Type: other] | 5-hydroxytryptamine receptor 2B [gi:1168220] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.731 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide) | | AID | 625217 | | BioAssay type | other | | Target | 5-hydroxytryptamine receptor 2B [gi:1168220] | | PubMed | | | Data Table |  |
|
| 23 | [SID103224720] | Active | IC50 | 0.759 | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625155, Type: other] | Muscarinic acetylcholine receptor M [gi:543761] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.759 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625155 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:543761] | | PubMed | | | Data Table |  |
|
| 24 | [SID103224720] | Active | IC50 | 0.759 | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625155, Type: other] | Muscarinic acetylcholine receptor M [gi:543761] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.759 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625155 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:543761] | | PubMed | | | Data Table |  |
|
| 25 | [SID103224720] | Active | IC50 | 0.759 | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625155, Type: other] | Muscarinic acetylcholine receptor M [gi:543761] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.759 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625155 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:543761] | | PubMed | | | Data Table |  |
|
| 26 | [SID103224720] | Active | IC50 | 0.759 | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625155, Type: other] | Muscarinic acetylcholine receptor M [gi:543761] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.759 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625155 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:543761] | | PubMed | | | Data Table |  |
|
| 27 | [SID103224720] | Active | IC50 | 0.762 | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625153, Type: other] | Muscarinic acetylcholine receptor M [gi:113125] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.762 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625153 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:113125] | | PubMed | | | Data Table |  |
|
| 28 | [SID103224720] | Active | IC50 | 0.762 | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625153, Type: other] | Muscarinic acetylcholine receptor M [gi:113125] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.762 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625153 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:113125] | | PubMed | | | Data Table |  |
|
| 29 | [SID103224720] | Active | IC50 | 0.762 | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625153, Type: other] | Muscarinic acetylcholine receptor M [gi:113125] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.762 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625153 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:113125] | | PubMed | | | Data Table |  |
|
| 30 | [SID103224720] | Active | IC50 | 0.762 | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625153, Type: other] | Muscarinic acetylcholine receptor M [gi:113125] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.762 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625153 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:113125] | | PubMed | | | Data Table |  |
|
| 31 | [SID103224720] | Active | IC50 | 0.762 | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) [AID625153, Type: other] | Muscarinic acetylcholine receptor M [gi:113125] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.762 [uM] | | BioAssay | DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine) | | AID | 625153 | | BioAssay type | other | | Target | Muscarinic acetylcholine receptor M [gi:113125] | | PubMed | | | Data Table |  |
|
| 32 | [SID103224720] | Active | IC50 | 0.776 | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) [AID625253, Type: other] | D(2) dopamine receptor [gi:118206] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.776 [uM] | | BioAssay | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) | | AID | 625253 | | BioAssay type | other | | Target | D(2) dopamine receptor [gi:118206] | | PubMed | | | Data Table |  |
|
| 33 | [SID103224720] | Active | IC50 | 0.776 | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) [AID625253, Type: other] | D(2) dopamine receptor [gi:118206] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.776 [uM] | | BioAssay | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) | | AID | 625253 | | BioAssay type | other | | Target | D(2) dopamine receptor [gi:118206] | | PubMed | | | Data Table |  |
|
| 34 | [SID103224720] | Active | IC50 | 0.776 | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) [AID625253, Type: other] | D(2) dopamine receptor [gi:118206] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.776 [uM] | | BioAssay | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) | | AID | 625253 | | BioAssay type | other | | Target | D(2) dopamine receptor [gi:118206] | | PubMed | | | Data Table |  |
|
| 35 | [SID103224720] | Active | IC50 | 0.776 | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) [AID625253, Type: other] | D(2) dopamine receptor [gi:118206] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.776 [uM] | | BioAssay | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) | | AID | 625253 | | BioAssay type | other | | Target | D(2) dopamine receptor [gi:118206] | | PubMed | | | Data Table |  |
|
| 36 | [SID103224720] | Active | IC50 | 0.776 | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) [AID625253, Type: other] | D(2) dopamine receptor [gi:118206] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.776 [uM] | | BioAssay | DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone) | | AID | 625253 | | BioAssay type | other | | Target | D(2) dopamine receptor [gi:118206] | | PubMed | | | Data Table |  |
|
| 37 | [SID103224720] | Active | IC50 | 0.823 | DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem) [AID625215, Type: other] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.823 [uM] | | BioAssay | DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem) | | AID | 625215 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID103224720] | Active | IC50 | 0.846 | DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine) [AID625216, Type: other] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.846 [uM] | | BioAssay | DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine) | | AID | 625216 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID103224720] | Active | IC50 | 0.906 | DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) [AID625199, Type: other] | Alpha-1B adrenergic receptor [gi:543734] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.906 [uM] | | BioAssay | DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) | | AID | 625199 | | BioAssay type | other | | Target | Alpha-1B adrenergic receptor [gi:543734] | | PubMed | | | Data Table |  |
|
| 40 | [SID103224720] | Active | IC50 | 0.906 | DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) [AID625199, Type: other] | Alpha-1B adrenergic receptor [gi:543734] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 0.906 [uM] | | BioAssay | DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin) | | AID | 625199 | | BioAssay type | other | | Target | Alpha-1B adrenergic receptor [gi:543734] | | PubMed | | | Data Table |  |
|
| 41 | [SID50103929] | Active | Potency | 1 | qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity [AID588834, Type: Literature] | KCNH2 gene product [Homo sapiens] [gi:325651834] |   View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 50103929 | | CID | 1547484 | | Outcome | Active | | Potency | 1 [uM] | | BioAssay | qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity | | AID | 588834 | | BioAssay type | Literature | | Target | KCNH2 gene product [Homo sapiens] [gi:325651834] | | PubMed | 19583963 | | Data Table |  |
|
| 42 | [SID50103929] | Active | Potency | 1 | qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity [AID588834, Type: Literature] | KCNH2 gene product [Homo sapiens] [gi:325651834] |   View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 50103929 | | CID | 1547484 | | Outcome | Active | | Potency | 1 [uM] | | BioAssay | qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity | | AID | 588834 | | BioAssay type | Literature | | Target | KCNH2 gene product [Homo sapiens] [gi:325651834] | | PubMed | 19583963 | | Data Table |  |
|
| 43 | [SID50103929] | Active | Potency | 1 | qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity [AID588834, Type: Literature] | KCNH2 gene product [Homo sapiens] [gi:325651834] |   View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 50103929 | | CID | 1547484 | | Outcome | Active | | Potency | 1 [uM] | | BioAssay | qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity | | AID | 588834 | | BioAssay type | Literature | | Target | KCNH2 gene product [Homo sapiens] [gi:325651834] | | PubMed | 19583963 | | Data Table |  |
|
| 44 | [SID50103929] | Active | Potency | 1 | qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity [AID588834, Type: Literature] | KCNH2 gene product [Homo sapiens] [gi:325651834] |   View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 50103929 | | CID | 1547484 | | Outcome | Active | | Potency | 1 [uM] | | BioAssay | qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity | | AID | 588834 | | BioAssay type | Literature | | Target | KCNH2 gene product [Homo sapiens] [gi:325651834] | | PubMed | 19583963 | | Data Table |  |
|
| 45 | [SID50103929] | Active | Potency | 1 | qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity [AID588834, Type: Literature] | KCNH2 gene product [Homo sapiens] [gi:325651834] |   View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 50103929 | | CID | 1547484 | | Outcome | Active | | Potency | 1 [uM] | | BioAssay | qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity | | AID | 588834 | | BioAssay type | Literature | | Target | KCNH2 gene product [Homo sapiens] [gi:325651834] | | PubMed | 19583963 | | Data Table |  |
|
| 46 | [SID103224720] | Active | IC50 | 1.083 | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT) [AID625190, Type: other] | |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 1.083 [uM] | | BioAssay | DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT) | | AID | 625190 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 47 | [SID103224720] | Active | IC50 | 1.09 | DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) [AID625222, Type: other] | Sodium-dependent serotonin transporter [gi:400630] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 1.09 [uM] | | BioAssay | DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) | | AID | 625222 | | BioAssay type | other | | Target | Sodium-dependent serotonin transporter [gi:400630] | | PubMed | | | Data Table |  |
|
| 48 | [SID103224720] | Active | IC50 | 1.09 | DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) [AID625222, Type: other] | Sodium-dependent serotonin transporter [gi:400630] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 1.09 [uM] | | BioAssay | DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) | | AID | 625222 | | BioAssay type | other | | Target | Sodium-dependent serotonin transporter [gi:400630] | | PubMed | | | Data Table |  |
|
| 49 | [SID103224720] | Active | IC50 | 1.09 | DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) [AID625222, Type: other] | Sodium-dependent serotonin transporter [gi:400630] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 1.09 [uM] | | BioAssay | DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine) | | AID | 625222 | | BioAssay type | other | | Target | Sodium-dependent serotonin transporter [gi:400630] | | PubMed | | | Data Table |  |
|
| 50 | [SID103224720] | Active | IC50 | 1.167 | DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) [AID625200, Type: other] | Alpha-1D adrenergic receptor [gi:1168243] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 103224720 | | CID | 1547484 | | Outcome | Active | | IC50 | 1.167 [uM] | | BioAssay | DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin) | | AID | 625200 | | BioAssay type | other | | Target | Alpha-1D adrenergic receptor [gi:1168243] | | PubMed | | | Data Table |  |
|